Skip to content

Study of effect of Tummy Soft Drops in babies with persistent crying.

A randomized, double-blind, placebo-controlled study of digestive enzymes, carminatives & probiotics (Tummy soft drops) in the management of Infantile colic in infants. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056153
Enrollment
100
Registered
2023-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

Intervention1: Tummy soft drops: 5 drops orally twice daily for 28 days Control Intervention1: Placebo: 5 drops orally twice daily for 28 days

Sponsors

Tablets India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Infants (age one month to 6 months) fulfilling the Rome-IV diagnostic criteria for infantile colic with no evidence of acute/ chronic illness. 2) Rome-IV diagnostic for clinical research purposes, diagnosis of infantile colic also includes both of the following: Caregiver reports infant has cried or fussed for three or more hours per day during three or more days in 7 days in a telephone or face-to-face screening interview. Total 24-h crying plus fussing in the selected group of infants is confirmed to be three h or more when measured by at least one prospectively kept 24-h behaviour diary. 3) Parents who report their infant crying excessively must be screened on an outpatient basis.

Exclusion criteria

Exclusion criteria: 1) Infants born before completing 34 weeks of gestation or birth weight 2) Infants with known gastrointestinal disorders, previous abdominal surgery, known galactosemia or diabetes mellitus will be excluded from the study. 3) Infants with severe dehydration. 4) Presence of systemic infections. 5) Infants with known immunocompromising morbidities. 6) Infants with severe acute malnutrition. 7) Infants with chronic or severe respiratory, cardiovascular, central nervous system, endocrine and other gastrointestinal disorders on clinical examination. 8) Infants with cystic fibrosis.

Design outcomes

Primary

MeasureTime frame
PRIMARY OUTCOME: After a 28-day study, the principal results would be a complete remission of complaints & a decrease in more than 50% of daily crying periods.Timepoint: 28 days

Secondary

MeasureTime frame
SECONDARY OUTCOME: Parental satisfaction on a Likert scale & occurrence of AEs (e.g.Milk regurgitation, vomiting, diarrhoea, constipation). AEs such as illness signs or symptoms that occur or worsen during the study through parental interviews after examining their daily records maintained in the dairy.Timepoint: 28 days

Countries

India

Contacts

Public ContactDr S Siva Sankar

Chettinad hospital and research institute

arunrmbbs1978@gmail.com9094752000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026